Immunic secures European patent for MS drug candidate vidofludimus calcium
Proactiveinvestors NA· 2026-03-10 12:38
About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...
QURE ALERT: FDA Reportedly Accuses uniQure of Pushing "Distorted" and "Manipulated" Data For "Failed" AMT-130 Drug Amid Pending Securities Class Action - Hagens Berman
Prnewswire· 2026-03-10 12:37
QURE ALERT: FDA Reportedly Accuses uniQure of Pushing "Distorted" and "Manipulated" Data For "Failed" AMT-130 Drug Amid Pending Securities Class Action - Hagens Berman Accessibility Statement Skip NavigationSAN FRANCISCO, March 10, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is updating its investigation into uniQure N.V. (NASDAQ: QURE) following an unprecedented public rebuke of the company by federal health officials. This investigation follows the filing of a securities class ...
Coherent's Rally Is Really About Optical Supply
Seeking Alpha· 2026-03-10 12:36
Coherent’s ( COHR ) bull run lately is supported by their increasing contribution to AI data center optics, where high-speed interconnects such as 800G and 1.6T are in increasing demand. The stock’s story is very interesting because opticalPythia Research focuses on multi-bagger stocks, primarily in the technology sector. Our approach combines financial analysis, behavioral finance, psychology, social sciences, and alternative metrics to assess companies with high conviction and asymmetric risk-reward poten ...
Michael Meyer resigns from the Board of Directors of RIAS A/S
Globenewswire· 2026-03-10 12:35
Michael Meyer resigns from the Board of Directors of RIAS A/S Attachment Michael Meyer resigns from the board of Directors of RIAS AS ...
Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026 11 AM EDT
Globenewswire· 2026-03-10 12:35
KING OF PRUSSIA, Pa., March 10, 2026 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that Mr. Robert Bitterman, CEO and Chairman of the Board, Phio Pharmaceuticals will present live at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com on March 12th, 2026. Mr. Bitterman will provide an overview of t ...
Inc. Names Didi Caldwell, President and CEO of Global Location Strategies, to Its 2026 Female Founders 500 List
Prnewswire· 2026-03-10 12:34
Inc. Names Didi Caldwell, President and CEO of Global Location Strategies, to Its 2026 Female Founders 500 List Accessibility Statement Skip NavigationInc.'s annual Female Founders list celebrates the nation's most innovative women entrepreneurs, who collectively generated approximately $12.3 billion in 2025GREENVILLE, S.C., March 10, 2026 /PRNewswire/ -- Global Location Strategies(GLS), the world's leading location strategy and site selection advisory firm, is proud to announce that President and CEO Didi ...
Virtune announces its crypto ETPs are now available for trading on Levler
Globenewswire· 2026-03-10 12:34
Stockholm, 10th of March 2026 - Virtune has entered into a collaboration with Levler to make crypto assets more accessible to Swedish investors. Through this collaboration, Levler’s customers can invest in Virtune’s crypto ETPs (exchange-traded products) just as easily as they trade stocks and funds on their existing platform. This enables Levler’s customers to build long-term exposure to crypto assets within their regular savings. Customers can also set up monthly savings plans in Virtune’s crypto ETPs wit ...
Navan, Inc. (NAVN) Shares Slide Amid Surprise Sales & Marketing Expense Increase Coincident with IPO, Securities Class Action Pending - Hagens Berman
Prnewswire· 2026-03-10 12:33
Navan, Inc. (NAVN) Shares Slide Amid Surprise Sales & Marketing Expense Increase Coincident with IPO, Securities Class Action Pending - Hagens Berman Accessibility Statement Skip NavigationNAVN Investors with Losses Encouraged to Contact Hagens BermanSAN FRANCISCO, March 10, 2026 /PRNewswire/ -- A securities class action lawsuit has been filed against Navan, Inc. (NASDAQ: NAVN), its IPO underwriters, and certain executives after the company's December 15, 2025 announcement of Q3 2026 quarterly financial res ...
Amprius Technologies (AMPX) Reports Earnings & Sees Analyst Coverage
Yahoo Finance· 2026-03-10 12:32
We recently published 9 Best Battery Stocks to Buy Before They Explode. Amprius Technologies Inc. (NYSE:AMPX) is one of the best battery stocks to buy before they explode. Investment firm B. Riley raised Amprius Technologies Inc. (NYSE:AMPX)’s share price target to $22 from $16 and kept a Buy rating on the shares on March 9th. The update came after the firm’s fiscal fourth quarter and full year 2025 earnings report. In its earnings, Amprius Technologies Inc. (NYSE:AMPX) had reported $25.2 million in fourt ...
Niagen Bioscience Launches Niagen® Skincare Innovation Lab and Debuts Dermatologist-Tested Niagen NanoCloud™, From Tru Niagen Powered by Patented Niagen®
Businesswire· 2026-03-10 12:32
LOS ANGELES--(BUSINESS WIRE)---- $NAGE #Biotech--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the launch of Niagen® Skincare Innovation Lab, a new product innovation platform designed to translate the Company's leadership in NAD+ science into category-defining skincare. Debuting under the platform is Niagen NanoCloudâ"¢, a limited-release, dermatologist-tested topical skincare product po ...